Soluble guanylate cyclase modulators—a novel therapeutic approach for diabetic kidney disease

Diabetic kidney disease (DKD) is a common complication, affecting approximately 40% of patients with diabetes and imposing substantial health and economic burdens worldwide. As DKD prevalence rises, existing treatments remain limited in efficacy, necessitating innovative therapeutic strategies. Solu...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yuqing Xu, Xuan Wu, Mingpai Ge, Kunhan Liang, Jixin Xing, Peng Zhang, Huilin Li, Zhiyong Guo, Xiaobin Mei
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2025-12-01
Sarja:	Renal Failure
Aiheet:	sGC modulators diabetic kidney disease proteinuria efficacy safety
Linkit:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2595385
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!